1. Introduction {#sec1}
===============

Malaria control is reliant on the use of insecticides. The dramatic reductions in malaria cases in Africa that have occurred over the last 15 years have been largely attributed to methods targeting the adult mosquito, primarily via the use of long lasting insecticidal nets (LLINs) treated with pyrethroids and, to a lesser extent indoor residual spraying (IRS) with pyrethroids and DDT and, more recently, carbamates and organophosphates ([@bib3], [@bib21]). Resistance to pyrethroids is now widespread in the major malaria vectors in Africa with resistance to other classes of public health insecticides also on the increase ([@bib21]). There is therefore an urgent need both for new insecticides to maintain the efficacy of these proven tools, and for new tools to reduce malaria transmission by the mosquito.

Pyriproxyfen (PPF) is a juvenile hormone analogue that inhibits metamorphosis. It has been used for several decades to protect against cotton pests ([@bib4]) and its extremely low toxicity to humans has also enabled applications in public health such as addition to water storage containers to control *Aedes* populations ([@bib7], [@bib14]). As PPF is active in very low concentrations, the active ingredient can be disseminated by the insect itself; this autodissemination route was shown to be effective at controlling *Aedes* populations in trials in Peru ([@bib9]). For malaria vectors, difficulties in identifying and treating the diverse breeding sites for malaria vectors have so far largely confined larviciding for malaria control to easy to reach urban areas but the possibility of using autodissemination strategies to distribute PPF to target *Anopheles* oviposition sites in rural areas is being explored. Currently, however, control of *Anopheles* mosquitoes is more commonly targeted at the adult stage, hence the impact of PPF on embryogenesis, shows the greatest promise for malaria control. Exposure to PPF effectively sterilizes female mosquitoes and has also been shown to reduce adult longevity ([@bib19], [@bib18]). Sumitomo Chemicals Ltd has developed a LLIN incorporating both permethrin and PPF. This Olyset Duo^®^, net has been shown to be effective in laboratory and experimental hut trials ([@bib2], [@bib18], [@bib19], [@bib27]) and is currently being evaluated in a randomised control trial in Burkina Faso to compare the efficacy of this combination net with conventional Olyset nets ([@bib25]).

However, concerns have been raised about the performance of Olyset Duo against pyrethroid resistant populations ([@bib12]). An experimental hut study of Olyset Duo carried out in an area where the *Anopheles gambiae* population has high levels of both target site and metabolic resistance to pyrethroids found no significant difference in the number of sterile mosquitoes in huts with Olyset Duo compared to control huts ([@bib12]).

Resistance to PPF has been reported in other insects including the greenhouse whitefly *Trialeurodes vaporiarium* ([@bib11]) and the sweet potato whitefly, *Bemisia tabaci* ([@bib20]). Although the mechanisms of resistance have not been fully described, elevated levels of genes involved in insect P450 and GST activity appear to be involved.

Several P450 enzymes have been implicated in the development of metabolic insecticide resistance in *An. gambiae* but a relatively small subset of this large enzyme family are consistently found up-regulated in pyrethroid resistant populations ([@bib8]; [@bib34]). This candidate list is predominated by three subfamilies of the CYP6 P450s: CYP6P, CYP6M and CYP6Z, but also includes CYP9J5 ([@bib10], [@bib26]) and the two CYP4G enzymes, CYP4G16 and 17 ([@bib35]; [@bib26]). CYP6M2 and CYP6P3 are confirmed pyrethroid metabolisers but are also active against insecticides from other insect classes ([@bib16], [@bib17], [@bib23]). In contrast the CYP4G enzymes do not have detectable activity against insecticides but instead are believed to confer resistance via reducing insecticide uptake ([@bib30]).

Here, we expressed the CYPs 6M2, 6P1, 6P2, 6P3, 6P4, 6P5, 6Z2 and 9J5 in *Escherichia coli* and assessed their ability to metabolize PPF. We also assessed the likelihood of cross resistance between PPF and other insecticide classes by comparing the efficacy of PPF in inhibiting metamorphosis and inducing female sterility in an insecticide susceptible strain of *An. gambiae* and a multiple resistant strain from Cote d'Ivoire.

2. Material and methods {#sec2}
=======================

2.1. Reagents {#sec2.1}
-------------

Oligonucleotides were synthesized by Eurofins genomics and enzymes for DNA manipulation were supplied by Thermo Scientific. Isopropyl-ß-D-thio-galactopyranoside (IPTG), 5-aminolevulinic acid (ALA), and 3-\[(3-cholamidopropyl)-dimethylammonio\]-1-propanesulfonate (CHAPS) were supplied by Melford (UK). Insecticides were supplied by ChemService: 3-phenoxybenzyl (1*R,S*)-*cis*,*trans*-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate (permethrin, mixture of isomers), (*S*)-α-cyano-3-phenoxybenzyl (1*R*,3*R*)-*cis*-2,2-dimethyl-3-(2,2-dibromovinyl)-cyclopropanecarboxylate (deltamethrin) and pyriproxyfen. HPLC solvents were supplied by Fisher Scientific. Other chemicals were obtained from Sigma-Aldrich unless indicated otherwise.

2.2. Gene cloning {#sec2.2}
-----------------

Total RNA was extracted with either the Arcturus PicoPure Kit (Applied Biosystems) or TRI reagent (Sigma-Aldrich) from ten adult *An. gambiae* mosquitoes from the Kisumu strain. Complementary DNA was prepared using Superscript III (Invitrogen) with an oligo(dT)~20~ primer and used as a template for amplifying full-length genes with KOD DNA polymerase (Merk Chemicals). The gene-specific primers used in these high-fidelity PCRs were designed according to the *An. gambiae* genome sequence ([Table S1](#appsec1){ref-type="sec"}). PCR products from P450s, summarized in [Table S2](#appsec1){ref-type="sec"}, were ligated into pGEM T-easy (Promega) and sequenced. For expression, the ompA leader sequence (ompA), was engineered onto the amino-terminus to direct the P450 to the *E. coli* outer membrane during expression as previously described ([@bib15], [@bib23]). The ompA-leader was fused to the P450 cDNA in frame with the P450 initiation codon by fusion PCR. The ompA-leader was fused to the P450 cDNA in frame with the P450 initiation codon by fusion PCR. The ompA P450 fusion was flanked at the 5′ and 3′ ends with NdeI and NotI respectively for ligation into NdeI/NotI digested pCWori+.

For CYP6M2 and CYP6P3 a single plasmid expression system for the P450 and CPR was constructed by ligating the expression cassette (cDNA and *tactac* promotor) containing the *An. gambiae* NADPH P450 reductase (CPR) cDNA from the pACYC:AgCPR plasmid described above into the pCW:P450 expression plasmid. In the new construct the expression of each protein is under the control of its own *tactac* promoter so expression of both proteins is induced by the addition of IPTG to the culture.

2.3. Preparation of membranes expressing P450 and AgCPR {#sec2.3}
-------------------------------------------------------

For dual plasmid co-expression of P450 and AgCPR (all P450s except CYP6M2 and CYP6P3), competent *E. coli* DH5α cells were co-transformed with pCW:P450 plasmid and pACYC:*AgCPR* ([@bib23]). Cultures, generally 0.2 l, were supplemented with 1.0 mM ALA and incubated at 23 °C for 18--24 h after 1 mM IPTG induction. P450 expression, *E. coli* membrane isolation and determination of P450 and AgCPR content was performed as previously described ([@bib15], [@bib24]). Samples were stored in aliquots at −80 °C. *An. gambiae* cytochrome *b*~5~ (b~5~) was prepared as described previously to supplement enzyme reactions at a 10:1 M ratio, b~5~:P450 ([@bib23]).

For CYP6M2 and CYP6P3, *E. coli* JM109 were transformed with the single plasmid system for the co-expression of AgCPR. Cultures were grown in 10 l stirred batch, glass fermenters and were harvested and processed to produce membrane fractions containing the CYP and CPR using the procedures described above, scaled to account for the larger culture volumes. Cytochrome *b*~*5*~ was added to the CYP6P3 bacterial membrane preparations at a 10:1 M ratio, b~5~:P450. After the addition of the cytochrome *b5* the membrane preparation was gently stirred at 4 °C for 30 min to allow time for the incorporation of the cytochrome *b5* into the membranes before aliquotting and freezing at −80 °C.

2.4. Pyriproxyfen metabolism {#sec2.4}
----------------------------

Incubations of a 200 μl reaction mix containing 20 μM insecticide, 0.1 μM of the recombinant enzyme, 1.0 μM b~5~, 0.2 M of TrisHCl at pH 7.4, 0.25 mM MgCl~2~, 1 mM glucose-6-phosphate, 0.1 mM NADP+ and 1 unit/mL glucose-6-phosphate dehydrogenase (G6PDH) were carried out in the presence or absence of 10 μM piperonyl butoxide (PBO) at 30 °C with shaking (1200 rpm) for 90 min and stopped by addition of 200 μl of methanol. Shaking was carried for an additional 10 min before centrifuging the reactions at 20000 *g* for 20 min. 150 μl of supernatant was used for HPLC analysis. Reactions were performed in triplicate and a paired *T*-test of sample reactions (+NADPH) vs negative control (-NADPH) used for statistical measurements of substrate depletion.

For reciprocal IC~50~ measurements of CYP6P3 metabolism of PPF and permethrin, enzyme reactions were carried out with PPF or permethrin added as inhibitors (at concentrations ranging from of 0--1.6 mM or 0--3.2 mM respectively) to the reaction mix to titer their effect on the insecticide turnover (fixed at 20 μM). Three replicates of positive and negative control reactions were run for each P450/inhibitor combination.

2.5. High-pressure liquid chromatography (HPLC) analysis {#sec2.5}
--------------------------------------------------------

Samples were analyzed by high-pressure liquid chromatography, HPLC (Agilent 1100 series). The quantity of insecticide remaining in the samples was determined by reverse-phase HPLC with a monitoring absorbance at 232 nm using a C18 column, Acclaim 120, Thermo Scientific. 100 μl of sample was loaded with a flow-rate 1 ml/min at 23 °C into an isocratic mobile phase 90% methanol and 10% water. The retention time for PPF is 7.4 min and for PBO 7.1 min.

The same conditions were applied for HPLC analysis for the PPF/permethrin inhibition assays. Retention time for trans- and cis-permethrin is 11.8 min and 14.1 min respectively.

2.6. Mass spectrometry analysis for pyriproxyfen metabolism {#sec2.6}
-----------------------------------------------------------

PPF metabolism by CYP6P3 was examined by mass spectrometry to confirm oxidation and identify the metabolites produced. Aliquots (5 μl) of organic solvent-quenched reaction supernatant were injected onto a high resolution Thermo Q-Exactive mass spectrometer (MS) that was coupled to a 1290 series Agilent LC system. The chromatographic separation was performed on a Waters Acquity BEH C18 (2.1 × 50 mm; 1.7 μm) analytical column at 30 °C using a mixture of water (0.1% formic acid) (A) and acetonitrile (0.1% formic acid) (B) as mobile phase. In the 12 min run time the gradient program was as follows: 5% B in 0--1 min; 5% B to 100% B in 1--8 min; 100% B in 8--10 min; 100% B to 5% B in 10--10.1 min; 5% B in 10.1--12 min. During the analysis the MS was operated in positive ion full scan mode (mass range: 100--1000 m/z) at 35 K resolution using a constant heated electrospray capillary temperature (320 °C), spray voltage (3500 V), sheath gas (55 arbitrary units) and auxiliary gas flow rate (10 arbitrary units).

2.7. Diethoxyfluorescein metabolism {#sec2.7}
-----------------------------------

Diethoxyfluorescein (DEF) substrate was dissolved in DMSO, with final concentration of 2% per assay. All test compounds were dissolved in DMSO, with a final solvent concentration \<2% per assay. For calculation of the kinetic parameters (K~M~ and V~max~), each P450 was used at a final concentration of 10 nM (1 pmol/reaction) and DEF concentrations in the range: 0, 0.31, 0.63, 1.25, 2.5, 5, 10 and 20 μM. DEF reactions were carried out at 25 °C in 50 mM KPi at pH 7.4 containing 1 mM glucose-6-phosphate (G6P), 0.1 mM NADP^+^, 0.25 mM MgCl~2~, and cytochrome *b*~5~ at a 10:1 M ratio, b~5~:P450. NADP^+^ and G6P were excluded from the minus NADPH controls.

Variable ligand concentrations were used for IC~50~ calculations with DEF used at ∼ K~M~ for each P450 (i.e. 0.5, 1.4, 0.7, 1.0, 3.5 and 0.5 μM for CYP6M2, CYP6P2, CYP6P3, CYP6P4, CYP9J5, and CYP6Z2 respectively) and 0.1 μM P450. Three replicates of positive and negative control reactions were run for each P450/substrate combination in opaque white 96-well (flat-based) plates in triplicate. The fluorescent reactions were monitored in a fluorescence plate-reader (Ex = 485 nm, Em = 520 nm) continuously over 20 min time period after the addition of NADPH regenerating system. The rate of fluorescent molecules produced per P450 molecule per min (turnover) was determined by linear regression of the measurements between 3 min and 10 min after the reactions began. The Michaelis-Menten and IC~50~ fitting calculations were performed using Graphpad Prism 6. Data were fitted to the dose-response model and plots with R^2^ \< 0.95 were rejected.

2.8. *In vivo* studies {#sec2.8}
----------------------

Two strains of mosquitoes were used to assess the impact of exposure to PPF on life history. The Kisumu strain of *An. gambiae* originates from Kenya and is susceptible to all insecticide classes used in public health whereas the Tiassalé strain from Cote d\'Ivoire shows resistance to four classes (pyrethroids, carbamates, organophosphates and the organochlorine DDT) ([@bib33]). Resistance in the Tiassalé strain is mediated by multiple mechanisms, including the overexpression of cytochrome P450s, notably CYP6P3, 6P4 and 6M2 ([@bib6]). Both mosquito strains were reared in the insectaries at the Liverpool School of Tropical Medicine under a 12:12 photoperiod at 27 °C and 70--80% humidity.

To measure the effect of PPF on metamorphosis, SumiLarv^®^0.5G (Sumitomo Chemicals Ltd) was ground into a fine powder and dissolved in water to prepare a stock solution of 1000 ppm SumiLarv (50 ppm active ingredient). The solution was left overnight dissolving on a magnetic stirrer, protected from light. Serial dilutions were prepared and the following PPF concentrations were tested: 0.001 ppb, 0.005 ppb, 0.07 ppb, 0.1 ppb, 1 ppb, 5 ppb and 10 ppb. Four replicates of 25 3rd instar mosquitoes were exposed to each of the SumiLarv concentrations in paper cups for up to 8 days. Larvae were fed Tetramin^®^ baby fish food every day and cups covered with netting to prevent adults escaping. The number of live and dead larvae, pupae and adults was recorded every 24 h until all individuals were emerged as adults or dead. Adults and dead pupae were removed daily. The Dose Effect function on XLSTAT (Microsoft) was used to estimate the concentration resulting in 50% emergence inhibition (EI50).

To compare the impact of PPF on adult mosquitoes of the two strains, we measured the ability of this compound to impair ovary development. Borosilicate glass tubes (30 cm long, 11 mm wide) were impregnated with three different concentrations of PPF (ai): 0.55 mg/m^2^, 2.75 mg/m^2^ and 5.5 mg/m^2^. An additional tube impregnated only with the solvent (acetone) was used as a negative control. Tubes were used on the day of preparation. Two groups of fifteen 5--7 days old female mosquitoes from Tiassalé and Kisumu strains were tested for each concentration (n = 30). After 60 min acclimation in paper cups, they were transferred to the glass tubes and exposed for 3 min. Mosquitoes were then returned to the paper cups and left for 24 h with a 10% sucrose solution. 24 h after exposure the mosquitoes were bloodfed and any mosquitoes which did not feed were removed. Mosquitoes were retained in insectary conditions with access to sugar water for five days and then dissected and the morphology of the ovaries assessed as normal (loose, well developed eggs) or abnormal (non-detachable, bubble-like eggs). Dead mosquitoes or mosquitoes not presenting egg development were discarded and removed from the analysis.

To confirm that formulated products containing PPF also impaired egg development, mosquitoes were exposed to Olyset Duo nets, nets containing 1% PPF only (supplied by Sumitomo Chemicals Ltd), conventional Olyset nets or untreated nets. Batches of 10 3--5 days old Tiassalé mosquitoes were exposed to the nets for 3 min following WHO standard protocols for cone bioassays. Twenty-four hours after the exposure, mosquitoes were bloodfed and left in paper cups with 10% sucrose solution. Dead and non-bloodfed mosquitoes were removed from the experiment. After 5 days surviving mosquitoes were dissected and the morphology of the ovaries examined as described above. To assess the effects of short exposures to PPF LLINs, an additional set of cone bioassays was performed, as described above, except exposure time was reduced to 30 s.

3. Results and discussion {#sec3}
=========================

This study was motivated by concerns over cross resistance between pyrethroid insecticides and the insect growth regulator, PPF. Cross resistance between insecticide classes with different modes of action, mediated by cytochrome P450s, has previously been demonstrated in *An. gambiae* ([@bib6], [@bib16]) and here we investigated whether these same P450 enzymes can also metabolize PPF. CYP6M2, CYP6P3 and CYP6Z2 have previously been expressed in bacterial expression systems but we extended the panel of recombinant enzymes to include a further three *An. gambiae* CYP6P P450s implicated in pyrethroid resistance in Cote d'Ivoire ([@bib6]) and CYP9J5, which has been found over expressed in pyrethroid resistant populations from Bioko Island ([@bib10]) and Burkina Faso ([@bib26]).

3.1. Functional expression of P450s in *E. coli* {#sec3.1}
------------------------------------------------

P450s require electrons from NADPH-cytochrome P450 oxido-reductase (CPR) for catalysis, thus new candidate *An. gambiae* P450s were co-expressed with AgCPR in *E. coli* using ompA and pelB leader sequences to direct the enzymes to the inner bacterial membrane as previously with CYP6M2 and CYP6P3 ([@bib17], [@bib23]). CYP\'s 6P1, 6P2, 6P4, 6P5, 9J5 and 6M1 were co-transformed with AgCPR-pACYC for *E. coli* expression, producing characteristic CO-reduced spectra indicative of active P450 ([Fig. S1](#appsec1){ref-type="sec"}). The yields of P450 were in the range 10--100 nmol/l, with CYP6P5 producing the lowest quantities of P450 (∼10 nmol/L; [Table S3](#appsec1){ref-type="sec"}). CYPs 6P1 and 6M1 failed to express functional P450.

CYP6M2 and CYP6P3 have previously been expressed following co-transformation with AgCPR on separate plasmids. Here, these enzymes were co-expressed in tandem with AgCPR on a single from the P450 expression plasmid, pCWori + to facilitate scaled 10 l fermentor expression. Tandem expression from the single plasmid produced higher CPR:P450 ratios. The fluorogenic substrate DEF was used to estimate the kinetic parameters of the tandemly expressed recombinant proteins against dual plasmid protein expression ([Table 1](#tbl1){ref-type="table"}) and used in dose-response experiments to determinate the inhibitory effect of permethrin, deltamethrin and pyriproxyfen in its metabolism. As expected, since CPR is rate limiting, the V~max~ values were 3--6 fold higher using the single plasmid in tandemly expressed membranes compared with dual plasmid expression, consistent with the elevated levels of CPR. The K~M~ value is the concentration of DEF required to reach max reaction velocity and independent of the enzyme concentration. The single versus double plasmid K~M~ values for CYP6M2 (0.4 vs 0.5 μM) and CYP6P3 (0.7 vs 0.9 μM) were similar, again consistent with higher CPR levels increasing reaction rates through enhanced electron transfer rather than effects on substrate binding.Table 1Kinetic parameters for DEF.Table 1P450Kinetic parameters for DEFSingle plasmid expressionDual plasmid expressionK~M~ (μM)V~max~ (RFU/sec)K~M~ (μM)V~max~ (RFU/sec)CYP6M20.4 ± 0.02902.2 ± 106.990.5 ± 0.01292.5 ± 38.05CYP6P30.7 ± 0.1054.4 ± 6.520.9 ± 0.0914.8 ± 4.89CYP6P2ntnt1.4 ± 0.02300.6 ± 12.00CYP6P4ntnt1.0 ± 0.0424.2 ± 1.26CYP9J5ntnt3.4 ± 0.21265.1 ± 28.75CYP6Z2ntnt0.5 ± 0.343.7 ± 8.9[^1]

3.2. PPF metabolism {#sec3.2}
-------------------

The ability of the *An. gambiae* P450s to metabolize PPF was tested by measuring substrate turnover (substrate disappearance over time) in the presence and absence of NADPH. We also included PBO in parallel reactions as further validation of P450 induced substrate depletion ([Fig. S2](#appsec1){ref-type="sec"}). PBO is an inhibitor of P450 monoxygenase activity and a common insecticide synergist ([@bib28]). All seven P450s metabolized PPF to some degree with the percentage PPF depletion ranging from 24.78% for CYP9J5 to 100% for CYP6P3, and PPF depletion was inhibited by PBO for each P450 tested ([Table 2](#tbl2){ref-type="table"}). Since *E. coli* membranes expressing CYP6M2 and CYP6P3 had higher levels of CPR, the rates of activity were not comparable with the rest of the P450s. However, it is notable that, with the exception of CYP6P5, all members of the CYP6P family and CYP6Z2 produced high levels of PPF depletion (58--100%). CYP6Z2 is of interest since it is found overexpressed in pyrethroid resistant populations of *An. gambiae*, but metabolises the pyrethroid metabolites 3-phenoxbenzoic alcohol and aldehyde rather than the parent compound ([@bib5]). Here CYP6Z2 appears to play a direct role in the primary metabolism of PPF, thus may have an influential role in PPF clearance and potentially insecticide resistance.Table 2Pyriproxyfen metabolism by mosquito P450s.Table 2P450% PPF depletionInhibition ratio (%)[a](#tbl2fna){ref-type="table-fn"}−PBO+ PBOCYP6M230.93 ± 4.651.44 ± 0.6795.3CYP6P258.03 ± 1.356.45 ± 3.2291.0CYP6P3100.0 ± 0.018.68 ± 1.7491.3CYP6P481.63 ± 0.634.44 ± 1.9994.6CYP6P539.96 ± 1.042.40 ± 2.0195.4CYP9J524.78 ± 2.130.08 ± 0.1599.6CYP6Z266.26 ± 3.028.41 ± 1.5887.3[^2]

Mass spectrometry analysis of the PPF metabolites generated by CYP6P3, the strongest metabolizer was carried out to confirm oxidation and identify possible metabolites. Expected metabolites included 4′-OH-PPF, 5″-OH- PPF and 5″,4′-OH-PPF, that have been previously identified from the *in vitro* metabolism of PPF by microsomes from housefly larvae ([@bib29]). CYP6P3 generated three metabolite peaks ([Fig. S3](#appsec1){ref-type="sec"}). The extracted ion chromatograms of \[M+H\]^+^ generated two peaks (6.9 min and 7.1 min), with molecular mass (m/z = 338.1387) corresponding to the addition of a hydroxyl group (m/z = 16), consistent with 4′-OH-pyriproxyfen and 5″-OH-pyriproxyfen production. Furthermore, the data showed signs of a metabolite with molecular mass 32 m/z larger than PPF, equivalent to a double hydroxylation, potentially 5″,4′-OH-PPF resulting from secondary metabolism of 5″-OH-PPF and/or 4′-OH-PPF metabolites. This was, however, not confirmed chromatographically as analytical reference standards were not available for the analysis. Further collision mass spectrometry or NMR is required to confirm the identity of the metabolites.

Since PPF is being used in combination with pyrethroids in bednets we were interested in potential synergistic effects. We therefore measured the IC~50~ values of PPF, deltamethrin and permethrin to compare relative strengths of DEF metabolism inhibition against the P450s ([Table 3](#tbl3){ref-type="table"}). The fluorescent substrate, DEF, was used for monitoring P450 activity using a 96 well microtiter plate format. In drug screens, compounds are generally categorized according to their activity as P450 inhibitors as potent inhibitors (IC~50~ \< 1 μM), moderate (IC~50~ 1--10 μM) and weak inhibitors (IC~50~ \> 10 μM) ([@bib13]). Using these criteria, PPF displayed moderate inhibition of DEF metabolism for CYP\'s 6Z2 and 6P2, with the remainder being weakly inhibited. Deltamethrin and permethrin were moderate inhibitors of DEF activity for all P450s apart from CYP6Z2, which was weakly inhibited by both pyrethroids. As Olyset Duo nets contain both PPF and permethrin, we also measured PPF inhibition of permethrin metabolism by CYP6P3 and vice versa ([Fig. 1](#fig1){ref-type="fig"}). CYP6P3 was chosen as it is one of the P450s most frequently found at elevated levels of expression in pyrethroid resistant populations of *An. gambiae*. Permethrin produced slightly stronger inhibition of PPF metabolism (IC~50~ = 61.2 μM) than PPF inhibition of permethrin metabolism (IC~50~ = 92.7 μM). Overall, the *in vitro* results suggest that the pyrethroids deltamethrin and permethrin are slightly stronger inhibitors (2--3 fold) than PPF against the pyrethroid metabolizing P450s tested.Table 3IC~50~ values for mosquito P450s.Table 3P450IC~50~ (μM)PyriproxyfenDeltamethrinPermethrinCYP6M214.144.248.07CYP6Z22.2313.9913.72CYP6P29.954.978.61CYP6P315.823.176.77CYP9J518.966.056.47Fig. 1**Determination of IC**~**50**~**values of permethrin and PPF in P450 metabolism**. Dose-response analysis of the inhibitory effect of (A) pyriproxyfen on permethrin metabolism and (B) permethrin on pyriproxyfen metabolism.Fig. 1

These data indicate that PPF can be metabolized by a wide range of P450s associated with pyrethroid resistance. In mosquitoes that have elevated levels of expression of one or more of these enzymes, it is feasible that enhanced metabolism of PPF could reduce the efficacy of this juvenile hormone analogue. To test this hypothesis we performed PPF bioassays on insecticide susceptible and resistant strains.

3.3. Bioefficacy of PPF against insecticide resistant mosquitoes {#sec3.3}
----------------------------------------------------------------

The impact of exposure to PPF on metamorphosis and embryogenesis was compared in the insecticide susceptible Kisumu strain and the multi resistant Tiassalé strain from Cote d'Ivoire. The dose-response tests showed that SumiLarv^®^ 0.5G affected adult mosquito emergence in both strains but the minimum dose that inhibited 100% emergence was 1 ppb in the insecticide susceptible Kisumu strain and 10 ppb in the Tiassalé strain. The concentration that resulted in 50% inhibition of emergence (EI~50~) for the susceptible Kisumu strain was 0.088 ppb (95% confidence intervals 0.064--0.123 ppb) ([Fig. 2](#fig2){ref-type="fig"}), similar to values reported for *An. gambiae s.l*. in other studies (0.025 ppb [@bib36], 0.13 ppb ([@bib38])). In contrast, the EI~50~ for the Tiassalé strain was 0.356 ppb ai (0.274--0.463) approximately 4-fold higher than the Kisumu strain. It is important to note that we cannot directly link the higher EI50 for PPF to the presence of elevated P450s in the Tiassale strain given that only one pyrethroid resistant population was evaluated and it is not known whether the same P450s found elevated in adults of this strain are also up-regulated at the larval stage. Furthermore, the field dose of SumiLarv 0.5G ranges from 10 to 50 ppb so it is likely that the product would still inhibit development of the Tiassalé strain under field conditions. However, given the trajectory of increasing pyrethroid resistance in both *Anopheles* ([@bib21]) and *Aedes* mosquitoes ([@bib31]) and the growing interest in use of PPF to target immature populations of these vectors ([@bib37]; [@bib1]) it is important that further evaluation of PPF efficacy against field populations is carried out.Fig. 2**SumiLarv emergence inhibition curves for two strains of *An. gambiae***. Emergence inhibition dose response curves for the insecticide susceptible Kisumu strain (continuous line) and insecticide resistant Tiassalé strain (dotted line). The grey dotted lines represent 95% upper and lower limits.Fig. 2

As the sterilizing effect of PPF on mosquito populations has also received considerable attention for malaria control, with clinical trials of the PPF/permethrin Olyset Duo LLIN ongoing ([@bib25], [@bib22]) we also compared inhibition of embryogenesis in our susceptible and resistant populations. In a narrow bore glass tube assay, designed to ensure complete contact with the PPF for the duration of the assay, mosquitoes from the insecticide susceptible Kisumu strain were completely sterilized after a 3 min exposure to 5.5 mg/m^2^ whereas only 75% of Tiassalé mosquitoes were sterilized by this dose. At half this dose, PPF had no impact on ovary development in Tiassalé but resulted in 76% of Kisumu mosquitoes being sterilized ([Fig. 3](#fig3){ref-type="fig"}). Thus higher concentrations of PPF are needed to sterilize the pyrethroid resistant strain, consistent with the effect on metamorphosis described above.Fig. 3**Effect of pyriproxyfen on egg development for two strains of *An. gambiae***. Proportions of normal/abnormal ovaries of mosquitoes from Tiassale and Kisumu strains exposed to three different concentrations of pyriproxyfen. The number over each bar corresponds to the sample size for each treatment.Fig. 3

3.4. Interactions between PPF and permethrin {#sec3.4}
--------------------------------------------

The *in vitro* analysis demonstrated that the same P450s can bind and metabolize PPF and pyrethroids. This interaction could have a synergizing effect with one chemical essentially reducing the rate of depletion of the other such that both chemicals are more potent when used in combination. As the pyrethroid IC~50~s were generally lower than for PPF (with the exception of CYP6Z2), pyrethroids might be expected to have a stronger enhancing effect on PPF activity than vice versa. However, the differences in IC~50~ values were small (∼2 fold) and, as the *in vivo* concentrations in mosquitoes after exposure to products containing PPF and/or permethrin are unknown, such predictions in isolation are highly speculative. Furthermore, as shown above, the performance of PPF varies between strains and thus the impact of combining the two chemistries in vector control products may depend on the level of expression of P450s in the strain.

To investigate this further we evaluated the performance of LLINs containing a single active ingredient versus the combination Olyset Duo LLIN in cone bioassays. The Tiassalé strain was exposed to four net types, mortality recorded 24 h after exposure and surviving mosquitoes were offered a bloodmeal. Ovary development was assessed after a further 5 days. As expected very low mortality was observed in the mosquitoes exposed to untreated or PPF only nets ([Table 4](#tbl4){ref-type="table"}). Mortality was higher after exposure to Olyset Duo nets than conventional Olyset nets (2-tailed z test, p = 0.02). All bloodfed mosquitoes exposed to the Olyset or untreated nets developed normal ovaries. In contrast all of the mosquitoes exposed to the 1% PPF net were sterilized. The number of surviving mosquitoes that successfully bloodfed from the Olyset Duo arm was small but surprisingly only 60% of these mosquitoes were sterilized. The differential sterilizing effect of nets containing 1% w/w PPF alone and Olyset Duo (with 1% PPF and 2% permethrin) was confirmed in follow up cone bioassay study in which mosquitoes were only exposed for 30 s. Here \>87% of Tiassalé mosquitoes exposed to PPF nets (n = 34 dissections) were sterilized versus 0% for untreated nets (n = 39) and only 16% for Olyset Duo nets (n = 38) ([Table S4](#appsec1){ref-type="sec"}).Table 4**Impact of exposure to LLINs containing permethrin and/or pyripoxyfen on mosquito mortality and egg development**. *An. gambiae* Tiassalé strain were exposed to the LLINs for 3 min. Mortality was measured 24 h later and surviving mosquitoes offered a blood meal. Ovary dissections were performed 5 days later. n bloodfed accounts for the number of surviving mosquitoes that fed on blood and survived for five days until ovary dissections.Table 4LLINnMortality % (95%CI)n bloodfedAbnormal% SterilizedUntreated452.22 (0.12--13.2)2300Olyset4630.4 (18.2--45.9)1900Olyset Duo4654.3 (39.2--68.8)10660PPF462.17 (0.11--13.0)3535100

Taken together these results suggest that PPF *increases* the efficacy of permethrin but permethrin *reduces* the efficacy of PPF. This is supported by data showing higher mortality rates in huts with Olyset Duo than with Olyset in areas with resistant mosquitoes ([@bib18] in Benin, [@bib12] in Cote d'Ivoire) (although no increase in the proportion of mosquitoes sterilized in huts containing PPF only nets versus Olyset Duo nets was observed, as our laboratory data would have predicted). It is important to note that these experiments are conducted on formulated products, and although the concentration of permethrin and PPF does not differ between net types, they may differ in their bleed rates affecting the bioavailability of the two active ingredients. Further laboratory and field evaluations, against vectors with differing levels of metabolic resistance, are needed to better predict the performance of combination products, such as Olyset Duo, in the field.

4. Conclusions {#sec4}
==============

Given that pyrethroid resistant populations of malaria vectors are now ubiquitous in Africa, it is important to evaluate the possible impact of this resistance on the performance of any new vector control tools. In this study we demonstrated that a subset of mosquito P450 enzymes responsible for elevated pyrethroid metabolism in insecticide resistant mosquitoes can also metabolize PPF. As metabolic resistance is an increasingly problematic resistance mechanism in African malaria vectors, there is a very real concern that PPF resistance may already be present in field population of *Anopheles* mosquitoes. Although the levels of PPF resistance we observed in the current study are low, continual monitoring for resistance to this chemistry should be undertaken in any area employing PPF as a larvicide or considering PPF use for adult mosquito control.
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[^1]: nt = not tested; (mean ± SD).

[^2]: Reduction of PPF depletion in percentage caused by the inhibitory effect of PBO; (mean ± SD).
